Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma
DNA methyltransferase 3A (DNMT3A) is an enzyme involved in DNA methylation that is frequently mutated in human hematologic malignancies. We have previously shown that inactivation of Dnmt3a in hematopoietic cells results in chronic lymphocytic leukemia in mice. Here we show that 12% of Dnmt3a-defici...
Main Authors: | Haney, Staci L., Upchurch, G. Michael, Opavska, Jana, Klinkebiel, David, Hlady, Ryan A., Roy, Sohini, Dutta, Samikshan, Datta, Kaustubh, Opavsky, Rene |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045215/ |
Similar Items
-
Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice
by: Haney, Staci L., et al.
Published: (2016) -
Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?
by: Upchurch, Garland Michael, et al.
Published: (2016) -
Angiogenic growth factor axis in autophagy regulation
by: Stanton, Marissa J., et al.
Published: (2013) -
NRP2 transcriptionally regulates its downstream effector WDFY1
by: Dutta, Samikshan, et al.
Published: (2016) -
Conditional haploinsufficiency of the retinoblastoma tumor suppressor gene
by: Ishak, Charles A, et al.
Published: (2014)